Sibel Blau, MD, president and CEO of the Quality Cancer Care Alliance (QCCA), talks about why QCCA and National Cancer Care Alliance (NCCA) launched Exigent Research.
Sibel Blau, MD, president and CEO of the Quality Cancer Care Alliance (QCCA), talks about why QCCA and National Cancer Care Alliance (NCCA) launched Exigent Research in July 2022.
Transcript
How does Exigent Research work?
Exigent Research is a network of independent oncologists that do good research and clinical trials in community oncology. Eighty percent of the patients are treated in community oncology, but unfortunately, only about 6.3% of the patients get into clinical trials in the community centers. There are many barriers for that.
At Exigent Research, we brought our strengths and learnings of many years doing research, and because of our data warehouse that has very special features that make it easy for us to do centralized services, we are hoping to reduce the burden of the administrative work and improve patient screening, feasibility, and enrollment into trials, and by dramatically changing how we do research, how we put patients into clinical trials in the community centers. We are going to be also developing technology and tools and really focusing on educating [and] training researchers and changing the mindset on how we do research in the community. That's how Exigent Research works.
Why did QCCA jointly launch Exigent Research with NCCA?
At QCCA, we have worked for years to develop a research network that had the features of the network we have now. In January 2020, just before COVID came, we actually established our research network, started building an infrastructure, and did proof-of-concept trials together [with] different models of research within the QCCA network members.
We have been working closely with NCCA with different projects. About December 2021, we learned that they also would like to do a research network. We're so similar minded and practices are so similar in the ways that [we] do research that we decided to come together. Within 6 months, QCCA and NCCA research came together, and now we have a combined company called Exigent Research Network.
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
April 30th 2024"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of Evidence-Based Oncology.
Read More